


January 2023 Top Biopharma Deal: Hutchmed – Takeda for cancer drug fruquintinib

December 2022 Top Biopharma Deal: Akeso – Summit for Cancer Drug Ivonescimab

November 2022 Top Biopharma Deal: POINT – Lantheus for cancer drugs PNT2002 and PNT2003

October 2022 Top Biopharma Deal: MacroGenics – Gilead for blood cancer drug MGD024
